Figures & data
Table 1. Baseline characteristics of tadalafil 5-mg and placebo patients
Table 2. Comparisons of the mean (SD) IELTs and total PEDT scores between the tadalafil 5-mg and placebo groups after 1 and 3 months
Table 3. PEDT scores at baseline
Table 4. PEDT scores after 1 month
Table 5. PEDT scores after 3 months
Table 6. Drug-related side-effects
Data availability statement
The data confidentiality was ensured. Data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.